DermatologyNews.net

Dermatology Xagena

Rosmarinus officinalis L. is a medicinal plant with diverse activities including enhancement microcapillary perfusion. A study has investigated the clinical efficacy of rosemary oil in the treatment ...


Rosmarinus officinalis L. is a medicinal plant with diverse activities including enhancement microcapillary perfusion. A study aimed to investigate the clinical efficacy of rosemary oil in the tre ...


Phase II trial results from investigational compound BI 655066 were presented at 73rd Annual Meeting of the American Academy of Dermatology. Nearly double the percentage of patients with moderate-to ...


In clinical practice, patients with psoriasis may require intermittent therapy as part of their long-term treatment programme. Those achieving Physician's Global Assessment ( PGA ) of less than or equ ...


Finasteride ( Propecia ) at a dose of 1 mg/d has been reported to show no significant improvement in 30–50% of patients with androgenetic alopecia. Dutasteride ( Avodart ), a dual inhibitor of both ...


The incidence of non-infectious uveitis on a background of psoriasis is estimated to be 7-20%. The use of tumor necrosis factor-alpha ( TNF-alpha ) inhibitors as a treatment for refractory uveitis is ...


The phase IIIb CLEAR study for Secukinumab ( Cosentyx ) has demonstrated superiority to Ustekinumab ( Stelara ) and met its primary endpoint of achieving PASI 90, which represents clear or almost clea ...


Psoriasis is a chronic inflammatory disease associated with increased risk of cardiovascular death. Several studies have shown a beneficial effect of anti-TNF-alpha therapy on the mechanisms associate ...


Results from additional efficacy and safety analyses of Apremilast ( Otezla ) from the ESTEEM phase III clinical trial program were presented at the 23rd European Academy of Dermatology and Venereolog ...


The Dermatologic and Ophthalmic Drugs Advisory Committee ( DODAC ) to the US Food and Drug Administration ( FDA ) has voted unanimously to support the approval of AIN457 ( Secukinumab ), a selective i ...


Results from a phase 2b dose-ranging study of Dupilumab, an investigational therapy, in adult patients with moderate-to-severe atopic dermatitis, a serious, chronic form of eczema were presented. All ...


Results from a phase 3 pivotal study demonstrating that Adalimumab ( Humira ) is effective in reducing common clinical signs and symptoms in moderate-to-severe hidradenitis suppurativa ( HS ), specifi ...


Thiazolidinediones ( also known as glitazones ) have shown to be efficacious with a favorable safety profile when used in the treatment of chronic plaque-type psoriasis. The aim of a study was to ...


Sentinel-node biopsy, a minimally invasive procedure for regional melanoma staging, was evaluated in a phase 3 trial. Researchers have evaluated outcomes in 2001 patients with primary cutaneous melan ...


In the BRIM-3 trial, Vemurafenib ( Zelboraf ) was associated with risk reduction versus Dacarbazine ( Deticene ) of both death and progression in patients with advanced BRAFV600 mutation-positive mela ...